-
Ivonescimab in NSCLC: Clinical Validation, Market Scenarios & Commercial Strategy
Price range: $1,500.00 through $3,500.00Select options This product has multiple variants. The options may be chosen on the product pageA strategic market intelligence report on Ivonescimab/AK112 in NSCLC, covering clinical validation, competitive positioning, regulatory catalysts, KOL sentiment, payer access, revenue scenarios, and commercial strategy after ASCO 2026.
Call us today: +1 (304) 470-2225
English
You can use WPML or Polylang and their language switchers in this area.